Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT02695290
Title Afatinib in EGFR+NSCLC (Recurrent or Stage IV) - Patients With Poor Performance Status (ECOG 2 or 3)
Recruitment Terminated
Gender both
Phase Phase III
Variant Requirements No
Sponsors Boehringer Ingelheim
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
1200.208.10032 Boehringer Ingelheim Investigational Site Fountain Valley California United States Details
*Shaded cells indicate that there was no data available from for the field